Novartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed ...

By Bhanvi Satija May 31 (Reuters) - Novartis said on Sunday that early data from its experimental actinium-based drug showed ...

The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

NHS advisors have again rejected pleas for potentially life-saving routine prostate cancer screening after concluding that ...

Only men with a specific gene variant and a family history of certain cancers should be screened, experts have said.

The majority of men in the UK will not be offered prostate cancer screening following a final recommendation from a committee ...

Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...

Low testosterone may increase the risk of aggressive prostate cancer progression during active surveillance. Learn more about the findings.

Government will consider committee’s guidance that says mass screening ‘likely to cause more harm than good’ ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

A new comprehensive review suggests that screening men for prostate cancer using a blood test could reduce deaths from the ...